Premiums are rising on healthcare deals, as drug companies scramble to secure a narrowing field...

|By:, SA News Editor
Premiums are rising on healthcare deals, as drug companies scramble to secure a narrowing field of companies with viable prospects. There's a "panicky quality to deals" now, says one I-banker, and premiums may be forced even higher as competition among buyers intensifies.